Global Apheresis Market Forecast to 2025 - Featuring Nikkiso, Macopharma SA & Miltenyi Biotec Among Others - ResearchAndMarkets.com

The "Apheresis Market by Product [Device (Centrifugation, Membrane Separation) Disposable], Procedure (Donor, Therapeutic), Application (Plasmapheresis, Plateletpheresis), Technology, End-User (Hospital, Blood Collection Center), Region - Global Forecast to 2025" report has been added to ResearchAndMarkets.com's offering.

The global apheresis market is projected to reach USD 2.7 billion by 2025 from USD 1.7 billion in 2019, at a CAGR of 8.1% during the forecast period.

The market for apheresis is primarily driven by the rising prevalence of chronic diseases and the growing number of trauma and injury cases, the increasing demand for source plasma from biopharmaceutical companies, the rising demand for blood components and growing concerns regarding blood safety, the increase in the number of complex surgical procedures, and the favorable reimbursement for apheresis procedures.

In 2018, the apheresis disposables segment accounted for the largest share of the market.

The large share of this segment can be attributed to its recurrent use, increasing blood donations using apheresis devices, increasing number of therapeutic apheresis procedures, and favorable reimbursement policies for apheresis procedures.

In 2018, the Automated Blood Collection (Donor Apheresis) segment accounted for the largest share of the market.

The large share of this segment can be attributed to the increasing number of blood component donations using apheresis devices and the increasing demand for source plasma from biopharmaceutical companies.

In 2018, the centrifugation segment accounted for the largest share of the market.

The large share of this segment can be attributed to the advantages offered by centrifugation over membrane separation, such as its high efficiency and its ability to separate all types of blood components.

In 2018, the plasmapheresis segment accounted for the largest share of the market.

The large share of this segment can be attributed to the increasing demand for plasma from biopharmaceutical companies and the use of plasmapheresis as a key therapeutic apheresis procedure.

In 2018, the blood collection centers and blood component providers segment accounted for the largest share of the market.

The large share of this segment is mainly attributed to the rising number of blood component donations, a growing number of blood centers, and increasing awareness.

APAC is projected to witness the highest growth during the forecast period.

The APAC market is estimated to register the highest CAGR during the forecast period. The growth in this market can be attributed to the rapid growth in geriatric population, improving healthcare infrastructure, increasing per capita income of the middle-class population in the region, rising focus of key market players on emerging APAC countries, and the increasing accessibility to a range of products with leading players entering these lucrative geographical regions.

The breakdown of primary participants was as mentioned below:

  • By Company Type: Tier 1-45%, Tier 2-30%, and Tier 3-25%
  • By Designation: C-level-35%, Director Level-25%, and Others-40%
  • By Region: North America-40%, Europe-20%, Asia Pacific-25%, Latin America-10%, Middle East & Africa-5%

Key Topics Covered:

1 Introduction

2 Research Methodology

3 Executive Summary

4 Premium Insights

4.1 Apheresis Market Overview

4.2 Europe: Apheresis Market, By Application

4.3 Geographic Snapshot of the Apheresis Market (2018)

4.4 Geographic Mix: Apheresis Market, 2019-2025 (USD Million)

4.5 Apheresis Market: Developing vs. Developed Markets, 2019 vs. 2025 (USD Million)

5 Market Overview

5.1 Introduction

5.2 Market Dynamics: Impact Analysis

5.2.1 Drivers

5.2.1.1 Rising Prevalence of Chronic Diseases and Growing Number of Trauma and Injury Cases

5.2.1.2 Increasing Demand for Source Plasma From Biopharmaceutical Companies

5.2.1.3 Rising Demand for Blood Components and Growing Concerns Regarding Blood Safety

5.2.1.4 Increase in the Number of Complex Surgical Procedures

5.2.1.5 Favorable Reimbursement for Apheresis Procedures

5.2.2 Restraints

5.2.2.1 High Cost of Apheresis Devices & Therapeutic Apheresis Procedures and Installation of Apheresis Devices Through Rental Model

5.2.2.2 Fewer Blood Donations Using Apheresis Due to Lack of Awareness

5.2.2.3 Stringent Donor Recruitment Criteria

5.2.3 Opportunities

5.2.3.1 Apheresis for Leukemia and Pediatric Patients

5.2.3.2 Emerging Economies With Increasing Investments From Government Bodies and Leading Players

5.2.4 Challenges

5.2.4.1 Recruitment of Voluntary Non-Remunerated Donors

5.2.4.2 Safety of Blood Transfusion in Developing Countries

6 Industry Insights

6.1 Industry Trends

6.1.1 New Indications for Plasma Products

6.1.2 Increasing Number of Collaborations, Agreements, and Partnerships

6.2 Porter's Five Force Analysis

6.3 Regulatory Analysis

7 Apheresis Market, By Product

7.1 Introduction

7.2 Apheresis Disposables

7.3 Apheresis Devices

8 Apheresis Market, By Procedure

8.1 Introduction

8.2 Automated Blood Collection (Donor Apheresis)

8.2.1 Increasing Number of Blood Component Donations Using Apheresis Devices to Support Market Growth

8.3 Therapeutic Apheresis

8.3.1 Therapeutic Apheresis Disposables

8.3.1.1 Neurological Disorders

8.3.1.2 Blood Disorders

8.3.1.3 Renal Disorders

8.3.1.4 Autoimmune Disorders

8.3.1.5 Metabolic Disorders

8.3.1.6 Cardiovascular Disorders

8.3.1.7 Other Disorders

8.3.2 Therapeutic Apheresis Devices

8.3.2.1 Centrifugation-Based Devices are One of the Most Commonly Adopted Therapeutic Apheresis Devices

9 Apheresis Market, By Technology

9.1 Introduction

9.2 Centrifugation

9.2.1 Continuous Flow Centrifugation

9.2.2 Intermittent Flow Centrifugation

9.3 Membrane Separation

9.3.1 Higher Efficacy of This Technology Accounts for Its High Usage in Developed Western European Countries and Japan

10 Apheresis Market, By Application

10.1 Introduction

10.2 Plasmapheresis

10.3 Plateletpheresis

10.4 Erythrocytapheresis

10.5 Leukapheresis

10.6 Photopheresis

10.7 Other Applications

11 Apheresis Market, By End User

11.1 Introduction

11.2 Blood Collection Centers & Blood Component Providers

11.2.1 Blood Collection Centers and Blood Component Providers Hold A Major Share of the Apheresis Market

11.3 Hospitals and Transfusion Centers

11.3.1 Hospitals and Transfusion Centers Segment is Expected to Grow at the Highest CAGR During the Forecast Period

11.4 Other End Users

12 Apheresis Market, By Region

12.1 Introduction

12.2 North America

12.2.1 US

12.2.1.1 The US Dominates the North American Apheresis Market

12.2.2 Canada

12.2.2.1 The Demand for Plasma Protein Products in Canada is on the Rise, Which is A Key Factor Driving Market Growth

12.3 Europe

12.4 Asia Pacific

12.5 Latin America

12.6 Middle East & Africa

13 Competitive Landscape

13.1 Overview

13.2 Market Share Analysis

13.3 Competitive Leadership Mapping

13.4 Competitive Situation and Trends

14 Company Profiles

14.1 Terumo BCT, Inc.

14.2 Fresenius Se & Co. KGaA

14.3 Haemonetics Corporation

14.4 Baxter International Inc.

14.5 Asahi Kasei Medical Co. Ltd. (A Subsidiary of Asahi Kasei Corporation)

14.6 B. Braun Melsungen AG

14.7 Cerus Corporation

14.8 Kaneka Corporation

14.9 Kawasumi Laboratories, Inc.

14.10 Nikkiso Co., Ltd.

14.11 Macopharma SA

14.12 Miltenyi Biotec

14.13 Otsuka Holdings Co., Ltd.

14.14 Medica Spa

14.15 Mallinckrodt Plc

14.16 Medicap Clinic GmbH

14.17 LMB Technologie GmbH

14.18 Bioelettronica Srl

14.19 Infomed

14.20 Cytosorbents Corporation

14.21 Toray Medical Co., Ltd.

For more information about this report visit https://www.researchandmarkets.com/r/bob8zr

View source version on businesswire.com: https://www.businesswire.com/news/home/20200214005188/en/

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900